This compound is a nucleoside analog pharmaceutical intermediate, a complex purine derivative with multiple protective groups. It is primarily used as a building block in the synthesis of nucleoside analog active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 251647-50-4
5'-O-DMT-N2-Isobutyryl-2'-O-methyl-D-guanosine
modified nucleoside for oligonucleotide synthesis
5'-O-DMT-2'-O-iBu-N-Bz-Guanosine
protected guanosine for oligonucleotide synthesis
Triethylamine 4-(((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl)oxy)-4-oxobutanoate
protected nucleoside intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
Pharmaceutical intermediate for oligonucleotide synthesis
2'-O-MOE-N6-Benzoyl-Adenosine Phosphoramidite
nucleoside phosphoramidite building block
Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
protected nucleoside phosphoramidite building block
Azetidinecarboxylic acid
proline analog for research
5-ETHYLBARBITURIC ACID
pharmaceutical intermediate for barbiturate synthesis
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
XDLPRZLZAFJSMA-BEGXHNNXSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OCCOC